The Inappropriate Use of GLP-1 Analogs: Reflections from Pharmacoepidemiology
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a potent therapeutic option for the management of obesity, demonstrating exceptional efficacy in several large-scale clinical trials. Despite their promising therapeutic outcomes, the rising popularity of these agents raises signi...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2024-11-01
|
| Collection: | Pharmacoepidemiology |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2813-0618/3/4/25 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|